Liraglutide

Liraglutide is a new type of hypoglycemic drug that activates AMP-activated protein kinase thus enhancing insulin sensitivity. It not only has a significant hypoglycemic effect, but also has the functions of weight loss, blood pressure reduction, and improvement of blood lipid profile.

Price Not Available inquiry Liraglutide Supplier Page
Catalog Number PIPB-0169
Alternative Name(s) Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
Research Area Peptide
Molecular Formula C172H265N43O51
CAS# 204656-20-2
Inchi Key YSDQQAXHVYUZIW-VTFFJMQZNA-N
Size inquiry
Supplier Page https://www.protheragen-ing.com/liraglutide-item-10287.html

Liraglutide

Liraglutide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to liraglutide therapy.

Price Not Available inquiry Liraglutide Supplier Page
Catalog Number API204656202
Alternative Name(s) NN2211 victoza NN-2211
Research Area Peptide APIs
Molecular Formula C172H265N43O51
CAS# 204656-20-2
Size inquiry
Supplier Page https://www.protheragen-ing.com/liraglutide-item-6091.html